In this regard, it should be noted the overexpression of ZAG in the adipose tissue rather than its serum levels is the main determinant of the lipolytic action of ZAG in the cancer-induced cachexia and also in end-stage-renal disease [17], [21], [27]. Here, AZGP1 is linked to stage 5 chronic kidney disease.